Company Guided Therapeutics Inc OTC Bulletin Board
Equities
US40171F3038
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-invasive Cervical Cancer Detection Device
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +653.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China, Southeast Asia (including Indonesia), Central & Eastern Europe and Saudi Arabia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +653.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 68 | 27/92/27 |
Founder | 68 | 27/92/27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Imhoff
BRD | Director/Board Member | 74 | 10/06/10 |
Richard Blumberg
BRD | Director/Board Member | 67 | 10/16/10 |
Mark Faupel
CEO | Chief Executive Officer | 68 | 27/92/27 |
Michael James
CHM | Chairman | 65 | 01/07/01 |
Alan Grujic
BRD | Director/Board Member | 56 | 08/23/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 900 | 0 | 0 | 56.20 % |
Stock B | 0 | 400 | 0 | 0 | |
Stock C | 0 | 2,700 | 0 | 0 | |
Stock D | 0 | 1,000 | 0 | 0 | |
Stock E | 0 | 300 | 0 | 0 | |
Stock F | 1 | 55,613,449 | 31,255,568 ( 56.20 %) | 0 | |
Stock G | 0 | 500 | 0 | 0 |
Company contact information
Guided Therapeutics, Inc.
5835 Peachtree Corners East Suite B
30092, Norcross
+770 242 8723
http://www.guidedinc.comSector
1st Jan change | Capi. | |
---|---|---|
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |